Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Proteomic analysis of energy metabolism and signal transduction in irradiated melanoma cells.

Yan LB, Shi K, Bing ZT, Sun YL, Shen Y.

Int J Ophthalmol. 2013 Jun 18;6(3):286-94. doi: 10.3980/j.issn.2222-3959.2013.03.06.

2.

Quantitative proteomic analysis for radiation-induced cell cycle suspension in 92-1 melanoma cell line.

Wang F, Bing Z, Zhang Y, Ao B, Zhang S, Ye C, He J, Ding N, Ye W, Xiong J, Sun J, Furusawa Y, Zhou G, Yang L.

J Radiat Res. 2013 Jul 1;54(4):649-62. doi: 10.1093/jrr/rrt010.

3.

Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance.

Masui O, White NM, DeSouza LV, Krakovska O, Matta A, Metias S, Khalil B, Romaschin AD, Honey RJ, Stewart R, Pace K, Bjarnason GA, Siu KW, Yousef GM.

Mol Cell Proteomics. 2013 Jan;12(1):132-44. doi: 10.1074/mcp.M112.020701.

4.

Human giant congenital melanocytic nevus exhibits potential proteomic alterations leading to melanotumorigenesis.

Kim HK, Kim YK, Song IS, Lee SR, Jeong SH, Kim MH, Seo DY, Kim N, Rhee BD, Ko KS, Tark KC, Park CG, Cho JY, Han J.

Proteome Sci. 2012 Aug 20;10(1):50. doi: 10.1186/1477-5956-10-50.

5.

Rapid verification of candidate serological biomarkers using gel-based, label-free multiple reaction monitoring.

Tang HY, Beer LA, Barnhart KT, Speicher DW.

J Proteome Res. 2011 Sep 2;10(9):4005-17. doi: 10.1021/pr2002098.

6.

Protein signatures for survival and recurrence in metastatic melanoma.

Hardesty WM, Kelley MC, Mi D, Low RL, Caprioli RM.

J Proteomics. 2011 Jun 10;74(7):1002-14. doi: 10.1016/j.jprot.2011.04.013.

Items per page

Supplemental Content

Support Center